The Role of the Radiologist and the Healthcare Team in Diagnosis and Management of Bronchiectasis
Released On
July 11, 2025
Expires On
October 11, 2025
Media Type
Internet
Completion Time
90 minutes
Specialty
Primary Care, Pulmonology, Radiology
Topics
Bronchiectasis
This activity is provided by National Jewish Health.
Supported by an educational grant from Insmed.
Credit Available
- Maximum of 1.5 AMA PRA Category 1 Credits™
Target Audience
Radiologists, pulmonologists and primary care physicians who care for patients with NCFBE and related diseases.
Program Overview
Non-cystic fibrosis bronchiectasis (NCFBE) is a progressive pulmonary condition that leads to bronchial wall damage and irreversible bronchial dilatation, which can severely impact a patient’s quality of life. Early detection of NCFBE can facilitate the appropriate treatment, which can break the vicious cycle of infection and inflammation and prevent further damage to the lungs. Radiologists play a central role in identifying bronchiectasis, and while they may not be directly involved in treating NCFBE patients, their role in clinical decision-making is crucial. In this activity, an expert panel of radiologists and pulmonologists will address clinical features of NCFBE, the importance of HRCT imaging for an early diagnosis, current and emerging treatment options, and strategies to improve time to diagnosis and ultimately improve patient health outcomes.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Understand the role of radiologic imaging, especially HRCT, in diagnosing NCFBE.
- Recognize the radiologic features of NCFBE, including bronchial dilatation, lack of bronchial tapering, and thickening of the airways.
- Evaluate current and emerging treatment options for patients with NCFBE and the role of early diagnosis.
- Develop an interdisciplinary approach for effectively communicating radiological findings to other healthcare team members to ensure an accurate and early diagnosis of NCFBE.
Faculty
Steven Lommatzsch, MD
Associate Professor of Medicine
Director, Non-CF Bronchiectasis Program
PCD Clinic Co-Director
Division of Pulmonary, Critical Care & Sleep Medicine
National Jewish Health
Denver, Colorado
David A. Lynch, MB BCh
Professor
Department of Radiology
National Jewish Health
Denver, Colorado
Seth Kligerman, MD
Professor
Chair, Department of Radiology
National Jewish Health
Denver, Colorado
Accreditation Statement
National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
National Jewish Health designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures of Conflicts Of Interest
In accordance with the Accreditation Council for Continuing Medical Education (ACCME), National Jewish Health requires that all program faculty, content developers, reviewers, and others in a position to control the content of this activity disclose to learners the presence or absence of any relevant financial relationships with an ACCME-defined ineligible company within the preceding 24 months of the activity. The ACCME defines an “ineligible company” as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Our goal is to ensure that there is no compromise in the ethical relationship that exists between those in a position to control the content of the activity and those participating in the activity and their respective professional duties. All accredited education activities offered by National Jewish Health are reviewed to ensure a balanced and evidence-based presentation.
All relevant financial relationships among individuals in a position to control the content of this activity have been identified and mitigated according to the Standards of Integrity and Independence in Accredited Continuing Education
Faculty Disclosures
- Steven Lommatzsch, MD reports the following relevant financial relationships:
- Investigator: Insmed, Sanofi
- Consultant: MannKind
- David Lynch, MB BCh reports the following relevant financial relationships:
- Advisory Board: Sanofi
- Consultant: Calyx/Perceptive, Boehringer Ingelheim Pharmaceuticals
Seth Kligerman, MD has no relevant financial relationships to disclose.
Planner and Reviewer Disclosures
Meghan Brenner, MA has no relevant financial relationships to disclose.
Bryce Chitanavong, MBA has no relevant financial relationships to disclose.
Andrea Harshman, MHA, CHCP has no relevant financial relationships to disclose.
Tilman Koelsch, MD has no relevant financial relationships to disclose.
Disclosure of relevant financial relationships are as follows:
Planners for this activity have no relevant financial relationships with any ineligible companies.
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Complete the post-test with a passing score of 2 out of 3 correct and submit the evaluation form.
Certificates will be immediately available to the participant.
Disclosure of Unlabeled Use
The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.
No endorsement of unapproved products or uses is made or implied by coverage of these products or uses. Please refer to the official prescribing information for each product for discussion of approved indicators, contraindications, and warnings.
Disclaimer
National Jewish Health (“NJH”) and its officers, Board of Directors, faculty, employees, representatives, and other agents (collectively, “NJH Parties”) shall not be responsible in any capacity for, and do not warrant any content whatsoever, in any NJH publication or other product (in any medium), or the use or reliance on any such content, and expressly disclaim any and all liability for such content. All such responsibility for content and use of product solely rests with the authors or the advertisers, as the case may be.
By way of example, without limiting the foregoing, this disclaimer of liability applies to the accuracy, completeness, effectiveness, quality, appearance, ideas, or products, as the case may be, of or resulting from, any statements, references, articles, positions, claimed diagnosis, claimed possible treatments, services, or advertising, express or implied, contained in any NJH live meeting, publication, online course or other product.
Furthermore, the content should not be considered medical advice and is not intended to replace consultation with a qualified medical professional. Under no circumstances, including negligence, shall any of the NJH Parties be liable for any DIRECT, INDIRECT, INCIDENTAL, SPECIAL or CONSEQUENTIAL DAMAGES, or LOST PROFITS that result from any of the foregoing, regardless of legal theory and whether or not claimant was advised of the possibility of such damages.
Contact Information
For CME questions please contact: [email protected].